Weiqian Chen

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Topics

Mesenchymal Stem Cells

Top Venues

Stem cell research & therapy

Bioengineering & translational medicine

Regenerative biomaterials

This page only lists publications with an associated author ORCID identifier.

Publications

Han Shen, Guanghao Cui, Yanqiong Li, Wenxue Ye, Yimin Sun, Zihan Zhang, Jingjing Li, Guiying Xu, Xiansheng Zeng, Yanxia Zhang, Wencheng Zhang, Zan Huang, Weiqian Chen, Zhenya Shen
Correction: Follistatin-like 1 protects mesenchymal stem cells from hypoxic damage and enhances their therapeutic efficacy in a mouse myocardial infarction model. Stem cell research & therapy 15 (1) (2024)
Han Shen, Guanghao Cui, Yanqiong Li, Wenxue Ye, Yimin Sun, Zihan Zhang, Jingjing Li, Guiying Xu, Xiansheng Zeng, Yanxia Zhang, Wencheng Zhang, Zan Huang, Weiqian Chen, Zhenya Shen
Correction: Follistatin-like 1 protects mesenchymal stem cells from hypoxic damage and enhances their therapeutic efficacy in a mouse myocardial infarction model. Stem cell research & therapy 15 (1) (2024)
Han Shen, Guanghao Cui, Yanqiong Li, Wenxue Ye, Yimin Sun, Zihan Zhang, Jingjing Li, Guiying Xu, Xiansheng Zeng, Yanxia Zhang, Wencheng Zhang, Zan Huang, Weiqian Chen, Zhenya Shen
Correction: Follistatin-like 1 protects mesenchymal stem cells from hypoxic damage and enhances their therapeutic efficacy in a mouse myocardial infarction model. Stem cell research & therapy 15 (1) (2024)
Ming Chen, Shengnan Wang, Yihuan Chen, Han Shen, Lei Chen, Liang Ding, Qingsong Tang, Ziying Yang, Weiqian Chen, Zhenya Shen
Precision cardiac targeting: empowering curcumin therapy through smart exosome-mediated drug delivery in myocardial infarction. Regenerative biomaterials 11 (2023)
Ming Chen, Shengnan Wang, Yihuan Chen, Han Shen, Lei Chen, Liang Ding, Qingsong Tang, Ziying Yang, Weiqian Chen, Zhenya Shen
Precision cardiac targeting: empowering curcumin therapy through smart exosome-mediated drug delivery in myocardial infarction. Regenerative biomaterials 11 (2023)
Liang Ding, Wenjing Zhou, Jian Zhang, Qingsong Tang, Weizhang Xiao, Ming Chen, Zhenya Shen, Weiqian Chen
Calming egress of inflammatory monocytes and related septic shock by therapeutic CCR2 silencing using macrophage-derived extracellular vesicles. Nanoscale 14 (13) (2022)
Weizhang Xiao, Ming Chen, Wenjing Zhou, Liang Ding, Ziying Yang, Lianbo Shao, Jingjing Li, Weiqian Chen, Zhenya Shen
An immunometabolic patch facilitates mesenchymal stromal/stem cell therapy for myocardial infarction through a macrophage-dependent mechanism. Bioengineering & translational medicine 8 (3) (2022)
Weizhang Xiao, Ming Chen, Wenjing Zhou, Liang Ding, Ziying Yang, Lianbo Shao, Jingjing Li, Weiqian Chen, Zhenya Shen
An immunometabolic patch facilitates mesenchymal stromal/stem cell therapy for myocardial infarction through a macrophage-dependent mechanism. Bioengineering & translational medicine 8 (3) (2022)
Weizhang Xiao, Ming Chen, Wenjing Zhou, Liang Ding, Ziying Yang, Lianbo Shao, Jingjing Li, Weiqian Chen, Zhenya Shen
An immunometabolic patch facilitates mesenchymal stromal/stem cell therapy for myocardial infarction through a macrophage-dependent mechanism. Bioengineering & translational medicine 8 (3) (2022)
Han Shen, Guanghao Cui, Yanqiong Li, Wenxue Ye, Yimin Sun, Zihan Zhang, Jingjing Li, Guiying Xu, Xiansheng Zeng, Yanxia Zhang, Wencheng Zhang, Zan Huang, Weiqian Chen, Zhenya Shen
Follistatin-like 1 protects mesenchymal stem cells from hypoxic damage and enhances their therapeutic efficacy in a mouse myocardial infarction model. Stem cell research & therapy 10 (1) (2019)